Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-25

Clinical Trial Update: The Efficacy and Safety of Empagliflozin - Linagliptin and Empagliflozin- Metformin Therapy in Reduction of Body Weight in Type 2 Diabetic Patients . [Phase 4]

View source ↗

Summary

A completed Phase 4 trial evaluated the efficacy and safety of empagliflozin combined with linagliptin versus empagliflozin combined with metformin for body wei…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Jardiance (empagliflozin)
  • Tradjenta (Linagliptin)
  • metformin (metformin)

Snippet

Sponsor: Bahria University | Conditions: Diabete Mellitus | Phase 4 | Status: COMPLETED